U.S. Neurosurgical Holdings, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020
August 14, 2020 at 04:08 pm EDT
Share
U.S. NeuroSurgical Holdings, Inc. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced sales was USD 596,000 compared to USD 825,000 a year ago. Operating income was USD 138,000 compared to USD 376,000 a year ago. Net income was USD 45,000 compared to net loss of USD 59,000 a year ago. Basic earnings per share was USD 0.01 compared to basic loss per share of USD 0.01 a year ago. For the half year, sales was USD 1.343 million compared to USD 1.666 million a year ago. Operating income was USD 504,000 compared to USD 823,000 a year ago. Net income was USD 220,000 compared to USD 127,000 a year ago. Basic earnings per share was USD 0.03 compared to USD 0.02 a year ago.
U.S. NeuroSurgical Holdings, Inc., through its wholly-owned subsidiaries, holds interests in radiological treatment facilities. The Company owns and operates stereotactic radiosurgery centers, utilizing gamma knife technology. It owns, or holds interests in, the gamma knife and radiation treatment centers, and charges the hospital or medical facility, where the unit is housed and maintained, based on utilization. It is also focused on developing cancer centers featuring radiation therapy. These centers utilize linear accelerators with Intensity Modulated Radiation Therapy and Image Guided Radiation Therapy capabilities. It is focused on launching and development of Medicare advantage plans for seniors by its subsidiaries, Elite Health Plan and Elite Health Plan of Nevada, Inc. Medicare is the federal health insurance program for people ages 65 and over, to cover people under 65 with certain disabilities and people with end-stage renal disease requiring dialysis or kidney transplant.
U.S. NEUROSURGICAL HOLDINGS, INC. 
